Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients
Frontiers in Nutrition · 05.06.2026 · 13
DOI: 10.3389/fnut.2026.1836021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 05.06.2026. Verfasst von Esra Canbolat Unlu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, I…. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH) 2 D) levels with clinical severity and mortality among hospitalized patients with moderate and severe COVID-19.
Methods
A total of 185 adult patients (≥18 years) with confirmed SARS-CoV-2 PCR positivity and without chronic kidney disease, admitted between March and May 2020, were included. Clinical characteristics, laboratory parameters, and serum 25(OH)D and 1,25(OH) 2 D levels were assessed. Factors associated with severe disease and mortality were determined using multivariate logistic regression and Cox regression analyses.
Results
Of the patients, 114 had moderate disease and 71 had severe disease. Length of hospital stay, intensive care unit (ICU) admission, and mortality rates were significantly higher in the severe group. While 25(OH)D levels were lower in the moderate group, 1,25(OH) 2 D levels were markedly reduced in severe cases. Multivariate analysis identified prolonged hospital stay, ICU admission history, and low 1,25(OH) 2 D levels were independently associated with severe disease. Independently associated factors with mortality were ICU admission ( p < 0.001), high troponin levels ( p = 0.003) and prolonged activated partial thromboplastin time (APTT) ( p = 0.04). Although vitamin D deficiency was associated with severe disease, it was not independently associated with mortality.
Conclusion
Reduced 1,25(OH) 2 D levels are associated with severe COVID-19 and may serve as a meaningful biomarker for predicting disease severity. These findings suggest that assessing 1,25(OH) 2 D levels may support clinical decision-making, particularly in patients at risk for severe COVID-19 or ARDS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye.
- Department of Clinical Biochemistry, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye.
Zitieren
APA
Canbolat Unlu, E., Karabela, S. N., Yesilbag, Z., Korkusuz, R., Borcak, D., Salim Dogdas, E., Senoglu, S., Isiksacan, N., & Kart Yasar, K. (2026). Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1836021
Vancouver
Canbolat Unlu E, Karabela SN, Yesilbag Z, Korkusuz R, Borcak D, Salim Dogdas E, et al. Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1836021
BibTeX
@article{CanbolatUnlu2026,
author = {Canbolat Unlu, Esra and Karabela, Semsi Nur and Yesilbag, Zuhal and Korkusuz, Ramazan and Borcak, Deniz and Salim Dogdas, Esra and Senoglu, Sevtap and Isiksacan, Nilgun and Kart Yasar, Kadriye},
title = {Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1836021}
}
EUVIMED